Introduction
Materials and methods
Breast cancer cell lines cultures and RNA preparation
Expression analysis
RNA no. | Microarray hybridisations | |||||||
---|---|---|---|---|---|---|---|---|
1 | BCAR3 (R/BCS) | BCAR3 (E2 6 h) | BCAR3 (R/BCS) | ZR-75-1 (E2 6 h) | ZR-75-1 (E2 7 d) | ZR-75-1 (E2 7 d) | ZR-75-1 (E2 7 d) | ZR-75-1 (E2 7 d) |
2 | BCAR1 (R/BCS) | BCAR3 (R/BCS) | ZR-75-1 (R/BCS) | ZR-75-1 (R/BCS) | ZR-75-1 (R/BCS) | BCAR1 (R/BCS) | BCAR3 (R/BCS) | ZR/EGFR (EGF 7 d) |
Quantitative RT–PCR
Gene | Sequence 5'→3' | |
---|---|---|
HPRT1
| F | TATTGTAATGACCAGTCAACAG |
R | GGTCCTTTTCACCAGCAAG | |
HMBS (= PBGD) | F | CATGTCTGGTAACGGCAATG |
R | GTACGAGGCTTTCAATGTTG | |
IGFBP5
| F | GGGTTTGCCTCAACGAAAAG |
R | TTTCTGCGGTCCTTCTTCAC | |
ESR1 (ERα) | F | GAGCACCCAGGGAAGCTAC |
R | CATCAGGTGGATCAAAGTGTC | |
CSTD (cathepsin D) | F | CACGGGCTCCTCCAACCT |
R | GGACTTGTCGCTGTTGTACTTGTG | |
TFF1 (PS2) | F | ATGGCCACCATGGAGAAC |
R | TTCACACTCCTCTTCTGG | |
MYC
| F | GAGCCCCTGGTGCTCCAT |
R | CGATTTCTTCCTCATCTTCTTGTTC | |
ESR2 (ERβ) | F | TCAGCCTGTTCGACCAAGTG |
R | GGCCTTGACACAGAGATATTC | |
PGR
| F | CAAGTTAGCCAAGAAGAGTTC |
R | ACTTCGTAGCCCTTCCAAAG | |
ERBB2 (HER2/Neu) | F | GTCTACAAGGGCATCTGGAT |
R | GTGGATGTCAGGCAGATGC | |
BCAR3
| F | GCGGTGGAACTGAAGGATTC |
R | TGGCAGTTTGGGTGTACTGG | |
BCAR1
| F | CTGCCCAGGATATTTACCAG |
R | CGTCATACACCTCCAGCAAC | |
EGFR
| F | CGGGACATAGTCAGCAGTG |
R | GCTGGGCACAGATGATTTTG | |
Gene | Product code | |
CDKN1A
| HS00355782_m1 | |
PGK1
| Hs99999906_m1 | |
IL1R1
| Hs00168392_m1 | |
CSTA
| Hs00193257_m1 | |
TFF3
| Hs00173625_m1 | |
FMOD
| Hs00157619_m1 | |
PDZK1
| Hs00420042_m1 | |
APOD
| Hs00155794_m1 | |
MGP
| Hs00179899_m1 | |
PSAT1
| Hs00253548_m1 |
Results
Overall gene expression
Effects of oestrogen and EGF on gene expression of ZR-75-1 human breast cancer cells
Effects of overexpression of BCAR1 or BCAR3 in ZR-75-1 cells
Verification of expression differences by quantitative PCR
ZR-75-1 cells | BCAR1-transfected cells | BCAR3-transfected cells | EGFR-transfected cells | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Addition...a
| None | ICI | Oestrogen | None | Oestrogen | None | Oestrogen | None | EGF | ||||||||
6 h | 6 h | 30 h | 96 h | Cont. | 6 h | 30 h | 96 h | 6 h | 30 h | 96 h | 3 days | 7 days | |||||
Gene | 3 (4)b
| 1 (1) | 2 (4) | 1 (1) | 1 (3) | 1 (3) | 2 (6) | 2 (3) | 1 (1) | 1 (1) | 2 (4) | 2 (3) | 1 (1) | 1 (1) | 1 (3) | 1 (2) | 1 (4) |
HMBS
| (23.1) 1c
| 0.58 | 0.79 | 0.42 | 0.49 | 1.22 | 0.93 | 0.75 | 0.51 | 0.93 | 0.59 | 0.56 | 0.41 | 0.64 | 0.93 | 0.80 | 0.99 |
FMOD
d
| (29.4) 1 | 1.60 | 1.47 | 0.79 | 1.04 | 0.95 | 0.58 | 0.83 | 0.71 | 0.81 | 0.95 | 1.09 | 1.00 | 1.59 | 1.02 | 0.94 | 0.54 |
PGK1
d
| (22.3) 1 | 1.33 | 1.02 | 1.08 | 1.18 | 1.18 | 1.41 | 0.94 | 1.07 | 1.61 | 1.46 | 2.10 | 0.97 | 2.11 | 0.70 | 2.23 | 0.94 |
CDKN1A
d
| (25.8) 1 | 0.60 | 0.72 | 0.47 | 0.66 | 2.03 | 1.45 | 1.24 | 0.61 | 1.34 | 1.19 | 1.37 | 0.81 | 1.78 | 1.26 | 2.11 | 3.60 |
MYC
| (23.3) 1 | 0.55 | 1.21 | 0.41 | 0.90 | 0.97 | 0.72 | 0.98 | 0.47 | 0.74 | 0.47 | 0.60 | 0.51 | 0.76 | 1.00 | 0.44 | 0.26 |
CTSD
| (18.7) 1 | 0.68 | 2.13 | 2.25 | 1.94 | 3.95 | 0.91 | 1.89 | 1.87 | 3.02 | 0.77 | 1.43 | 1.90 | 4.21 | 1.78 | 2.38 | 1.95 |
TFF1
| (21.2) 1 | 0.56 | 2.07 | 9.28 | 20.45 | 36.67 | 0.99 | 2.38 | 13.37 | 32.60 | 0.94 | 1.35 | 9.30 | 21.37 | 4.71 | 5.77 | 2.64 |
PGR
| (24.6) 1 | 0.71 | 9.08 | 9.24 | 12.00 | 7.52 | 0.83 | 7.24 | 9.29 | 7.65 | 0.38 | 2.22 | 3.55 | 5.62 | 0.56 | 0.32 | 0.05 |
PDKZ1
d
| (26.4) 1 | 0.92 | 5.26 | 14.75 | 10.12 | 16.66 | 0.64 | 1.85 | 11.86 | 11.81 | 0.52 | 1.93 | 7.26 | 9.10 | 1.17 | 0.08 | 0.03 |
TFF3
d
| (23.0) 1 | 0.50 | 1.03 | 2.64 | 6.19 | 11.56 | 0.84 | 1.30 | 2.60 | 7.29 | 1.21 | 1.23 | 2.22 | 4.02 | 1.09 | 0.79 | 0.10 |
MGP
d
| (22.8) 1 | 0.83 | 1.09 | 1.54 | 2.99 | 1.34 | 0.93 | 1.00 | 3.12 | 3.15 | 0.89 | 0.78 | 2.14 | 1.11 | 0.42 | 0.86 | 0.23 |
IGFBP5
| (17.6) 1 | 0.80 | 0.92 | 0.24 | 0.45 | 0.17 | 0.91 | 0.74 | 0.27 | 0.49 | 0.33 | 0.30 | 0.22 | 0.28 | 1.46 | 0.04 | 0.01 |
APOD
d
| (21.5) 1 | 0.96 | 0.89 | 0.53 | 0.25 | 0.09 | 0.37 | 0.36 | 0.18 | 0.08 | 0.60 | 0.59 | 0.36 | 0.27 | 0.32 | 0.02 | 0.04 |
CSTA
d
| (27.7) 1 | 0.57 | 0.86 | 0.08 | 0.06 | 0.06 | 0.74 | 0.53 | 0.08 | 0.09 | 2.95 | 2.86 | 0.88 | 0.44 | 0.04 | 0.01 | 0.02 |
HER2/Neu
| (20.4) 1 | 0.77 | 0.75 | 0.18 | 0.29 | 0.39 | 0.73 | 0.48 | 0.20 | 0.25 | 0.68 | 0.53 | 0.29 | 0.37 | 1.16 | 0.51 | 0.49 |
IL1R1
d
| (27.5) 1 | 0.76 | 0.50 | 0.10 | 0.09 | 0.04 | 1.54 | 0.54 | 0.07 | 0.15 | 0.64 | 0.40 | 0.14 | 0.23 | 0.84 | 0.12 | 0.21 |
ERα
| (20.2) 1 | 0.54 | 0.86 | 0.36 | 0.41 | 0.27 | 0.50 | 0.55 | 0.31 | 0.29 | 0.35 | 0.39 | 0.28 | 0.33 | 0.79 | 0.12 | 0.07 |
ERβ
| (32.7) 1 | 1.21 | 1.93 | 0.05 | 1.57 | 1.62 | 1.61 | 1.40 | 0.63 | 0.60 | 0.84 | 1.78 | 0.42 | 3.19 | 1.58 | 1.08 | 1.89 |
BCAR3
| (24.2) 1 | 0.74 | 0.51 | 0.40 | 0.46 | 0.45 | 0.64 | 0.25 | 0.14 | 0.23 | 18.30 | 14.36 | 13.19 | 24.78 | 0.35 | 0.60 | 0.69 |
BCAR1
| (24.8) 1 | 0.93 | 1.17 | 0.71 | 0.69 | 1.31 | 55.96 | 31.90 | 13.67 | 22.12 | 0.80 | 1.01 | 0.58 | 0.36 | 1.01 | 1.13 | 1.07 |
PSAT1
d
| (35.6) 1 | 0.86 | 0.67 | 0.40 | 0.97 | 2.64 | <0.01 | <0.01 | <0.01 | <0.01 | 0.87 | 1.16 | 0.84 | 0.76 | 1.65 | 3.36 | 3.64 |
EGFR
| (35.0) 1 | 0.25 | 0.84 | 1.62 | 1.75 | 1.27 | 1.47 | 2.56 | 2.31 | 1.25 | 2.24 | 2.15 | 2.75 | 4.13 | 8126 | 11045 | 10582 |